Archive


Category: $150M

  • Labcorp to Acquire Myriad’s Vectra Testing Business for $150M

    Shots: Labcorb acquires the Vectra RA test from Myriad Genetics along with other operating assets and IP for $150M in cash. The transaction is expected to close in Q3’21 The divestiture of Myriad auto immune’s Vectra testing business allow Labcorb to bolster its rheumatology and autoimmune portfolios Vectra is a non-invasive, blood-based test that analyzes […]

  • Labcorp to Acquire Myriad’s Vectra Testing Business for $150M

    Shots: Labcorb acquires the Vectra RA test from Myriad Genetics along with other operating assets and IP for $150M in cash. The transaction is expected to close in Q3’21 The divestiture of Myriad auto immune’s Vectra testing business allow Labcorb to bolster its rheumatology and autoimmune portfolios Vectra is a non-invasive, blood-based test that analyzes […]